UAB Digital Repository of Documents 2 records found  Search took 0.02 seconds. 
1.
24 p, 3.2 MB Neuroprotective Effects of Exercise Treatments After Injury : The Dual Role of Neurotrophic Factors / Cobianchi, Stefano (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Arbat-Plana, Ariadna (Universitat Autònoma de Barcelona. Institut de Neurociències) ; López-Álvarez, Víctor M. (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Navarro, Xavier (Universitat Autònoma de Barcelona. Institut de Neurociències)
Shared connections between physical activity and neuroprotection have been studied for decades, but the mechanisms underlying this effect of specific exercise were only recently brought to light. Several evidences suggest that physical activity may be a reasonable and beneficial method to improve functional recovery in both peripheral and central nerve injuries and to delay functional decay in neurodegenerative diseases. [...]
2017 - 10.2174/1570159X14666160330105132
Current neuropharmacology, Vol. 15 (may 2017) , p. 495-518  
2.
24 p, 1.3 MB Shining Light On An mGlu5 Photoswitchable NAM : A Theoretical Perspective / Dalton, James A.R. (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Lans, Isaias (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Rovira Algans, Xavier (Institut de Génomique Fonctionnelle) ; Malhaire, Fanny (Institut de Génomique Fonctionnelle) ; Gómez-Santacana, Xavier (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Pittolo, Silvia (Institute for Bioengineering of Catalonia (IBEC)) ; Gorostiza, Pau (Institute for Bioengineering of Catalonia (IBEC)) ; Llebaria, Amadeu (Institut de Química Avançada de Catalunya) ; Goudet, Cyril (Institut de Génomique Fonctionnelle) ; Pin, Jean-Philippe (Institut de Génomique Fonctionnelle) ; Giraldo, Jesús (Universitat Autònoma de Barcelona. Institut de Neurociències)
Metabotropic glutamate receptors (mGluRs) are important drug targets because of their involvement in several neurological diseases. Among mGluRs, mGlu5 is a particularly high-profile target because its positive or negative allosteric modulation can potentially treat schizophrenia or anxiety and chronic pain, respectively. [...]
2016 - 10.2174/1570159X13666150407231417
Current neuropharmacology, Vol. 14, Num. 5 (July 2016) , p. 441-454
2 documents

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.